he described the failure to send the patient for a ct scan on her hip as another "missed opportunity". .
elizabeth loder, md, professor of neurology, harvard medical school; chief, division of headache, brigham & women's hospital. . .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. . . .